Cameron Shumway

Cameron Shumway practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Cameron Shumway's NPI, 1366801805, was assigned on February 11, 2016. Cameron Shumway holds Idaho license 5101024647.

Cameron Shumway's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Cameron Shumway's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Cameron Shumway is also affiliated with Bonner General Health. The medical group on file is Kootenai Health. Dmand AI also links Cameron Shumway to 2 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account. Cameron Shumway's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Cameron Shumway practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Cameron Shumway's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Cameron Shumway is licensed in Idaho.

CMS data shows 1,131 Medicare services from Cameron Shumway across 10 procedure codes in 2024, for 306 Medicare patients. Medicare paid $79,259 for them.

CMS counts 306 Medicare patients who saw Cameron Shumway in 2024. The largest group is 65 to 74, with 134 patients. 74% of them have high blood pressure, and 65% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cameron Shumway's median patient age at 75, with 59% women.

In 2024, Cameron Shumway wrote 1,149 Medicare Part D claims for 188 patients. 72% of them were for generic drugs. CMS names the drug for 854 of them, across 26 drugs with 11 or more claims each, at $2,286,570 in total drug cost. In 2023, CMS named 637 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Cameron Shumway for performance year 2024, reported through an alternative payment model (APM). Cameron Shumway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cameron Shumway as offering telehealth.

Dmand AI links 1 paper to Cameron Shumway in 2019. Cameron Shumway's most frequent co-author is Min Cho, DO.

CMS Open Payments shows 80 general payments to Cameron Shumway from 15 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $604.